Susquehanna International Group’s Stoke Therapeutics STOK Stock Holding History

Susquehanna International Group’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Buy	34,700 +8,500	+32%	+$279K	﹤0.01%	7560
2025 Q4	$832K	Sell	26,200 -14,300	-35%	-$430K	﹤0.01%	7590
2025 Q3	$952K	Sell	40,500 -16,300	-29%	-$279K	﹤0.01%	7476
2025 Q2	$645K	Sell	56,800 -50,400	-47%	-$479K	﹤0.01%	8578
2025 Q1	$713K	Buy	107,200 +92,300	+619%	+$861K	﹤0.01%	8100
2024 Q4	$164K	Buy	14,900 +3,000	+25%	+$36.9K	﹤0.01%	10943
2024 Q3	$146K	Buy	+11,900	New	+$169K	﹤0.01%	10767
2024 Q2	–	Sell	-10,100	Closed	-$136K	–	13196
2024 Q1	$136K	Buy	+10,100	New	+$61.2K	﹤0.01%	10982
2021 Q4	–	Sell	-29,300	Closed	-$745K	–	13878
2021 Q3	$745K	Buy	+29,300	New	+$817K	﹤0.01%	8338
2021 Q1	–	Sell	-3,800	Closed	-$235K	–	12825
2020 Q4	$235K	Buy	+3,800	New	+$174K	﹤0.01%	9775

Other funds holding STOK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Susquehanna International Group's STOK Position: Q1 2026 in Review

Susquehanna International Group increased its Stoke Therapeutics (STOK) stake by 24% in Q1 2026, buying an estimated $370K and bringing the position to 57,291 shares worth $1.87M. The position accounts for ﹤0.01% of the portfolio, ranked #6333.

Susquehanna International Group first reported a position in STOK in Q1 2020 and has held it in 21 quarters since. The position peaked at $2.07M in Q4 2024. 196 funds tracked by Wall St. Rank hold STOK as of Q1 2026.

Susquehanna International Group held 57,291 shares of Stoke Therapeutics worth $1.87M as of Q1 2026.
Susquehanna International Group bought 11,269 Stoke Therapeutics shares in Q1 2026, an estimated $370K.
Stoke Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6333 holding.
Susquehanna International Group first reported a position in Stoke Therapeutics in Q1 2020 and has held it in 21 quarters since.
Susquehanna International Group's Stoke Therapeutics position peaked at $2.07M in Q4 2024.
196 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.